Patient characteristics and treatment information
| TIN (n = 11) | RPT (n = 27) | P Value | |
|---|---|---|---|
| Age (yr), (mean) (range) | 45.3 ± 15.1 | 51.6 ± 13.5 | |
| (19–73) | (28–79) | .213 | |
| Sex (M/F) | 9:2 | 18:9 | .350 |
| Extent of first surgery for primary tumor | .762 | ||
| Biopsy | 2 (20%) | 3 (11%) | |
| STR | 6 (60%) | 17 (63%) | |
| GTR | 2 (20%) | 7 (26%) | |
| Adjuvant therapy | .861 | ||
| RT + chemotherapy (No.) | 10 (91%) | 25 (93%) | |
| RT (No.) | 1 (9%) | 2 (7%) | |
| Time interval between RT and appearance of RPT (mo) | 15 | 13 | .602 |
| Median (range) | (7–96) | (2–150) | |
| Steroids at the time of PCT examination (No.) | 1 (9%) | 9 (33%) | .123 |
| Time between PCT and surgery for the RPT (days) (median) (range) | 17 | 7 | .139 |
| (1–157) | (1–151) | ||
| Extent of second surgery for the RPT | .092 | ||
| Biopsy (No.) | 3 (27%) | 1 (4%) | |
| STR (No.) | 7 (64%) | 24 (89%) | |
| GTR (No.) | 1 (9%) | 2 (7%) |